Description

MicroPort Scientific Corporation, an investment holding company founded in Shanghai, China, in 1998, is a global enterprise dedicated to the development, manufacturing, and commercialization of medical devices. Its operations span across China, North America, Europe, other Asian nations, and South America. The company's diverse product portfolio is structured into several key divisions. The Cardiovascular Devices segment provides solutions for coronary artery diseases, including advanced coronary stents, their associated delivery systems, and various balloon catheters. Its Orthopedics Devices division offers reconstructive joint replacements, spine and trauma implants, and specialized surgical instruments. The Cardiac Rhythm Management Business focuses on devices for diagnosing and treating heart rhythm disorders and heart failure, such as defibrillators, cardiac resynchronization therapy devices, and pacemakers. MicroPort's Endovascular and Peripheral Vascular Devices segment develops interventional treatments for conditions like thoracic and abdominal aortic aneurysms, peripheral vascular diseases, and aortic dissection. The Neurovascular Devices segment provides therapeutic and access tools specifically designed for neurovascular ailments. Within the Heart Valve Business, offerings include the VitaFlow Transcatheter aortic valve and its delivery system, the VitaFlow Liberty Transcatheter aortic valve implantation and retrieval systems, the Alwide Plus Balloon Catheter, alongside various other transcatheter and surgical valves for aortic, mitral, and tricuspid applications. Furthermore, the Surgical Robot Business is actively engaged in the design, engineering, and market introduction of sophisticated surgical robotics, incorporating elements such as robot ontology, control algorithms, electrical engineering, image-based navigation, and precision imaging. Lastly, the Surgical Devices segment is responsible for the research, development, production, and sale of general surgical instruments.